The National Strategic Plan for HIV/AIDS and STI 2017-2024 in India aims to achieve an AIDS-free India through universal access to prevention, treatment, and care services by 2024. Key goals include reducing new HIV infections by 80% and ensuring 95% of people living with HIV are aware of their status and on antiretroviral treatment. The plan leverages integration with public health systems and engages the private sector to expand testing, treatment, and prevention of mother-to-child transmission of HIV. Progress will be monitored based on indicators like the percentage of people on treatment who are virally suppressed and the reduction in new infections and HIV-related deaths.

1. National Strategic Plan
For HIV/AIDS and STI
2017-2024
“Paving Way for an AIDS Free India”

2. Back ground
• First case of HIV in India -1986.
• NACP – 1987 ---Four phases.
• NACP IV- 2012-2017.
• NSP-2017-2024, frame work document.
• Designed for a period of Seven years.

3. • 66% reduction in new infections from 2000-
2015.
• 54% reduction in AIDS related deaths since
2007.
• 2.3 million PLHIV in India (2019).
• 28% of PLHIV do not know their HIV status.
• Around 6000 PLHIV in J&K.

4. Vision
• An AIDS Free India.
• It was framed in tune with SDG 3, That
encompasses:
• “Ending of AIDS by 2030”.

5. Mission
• Attain universal coverage of HIV prevention,
treatment to care continuum that are
effective, inclusive, equitable and adapted to
needs.

6. Goals
• Achieving Zero new infections
• Zero AIDS related death
• Zero discrimination

7. Strategic Framework

8. Prevent
• Increased coverage for improved prevention,
testing and care linkages.
• Systematic evidence generation to reach 'at
risk' population.
• Retain Key Population with adequate and
appropriate services.

9. TEST
• Geo-prioritise differential approach.
• Use graded approach to increase HIV testing.
• Pilot and scale up newer modalities of testing
(e.g. CBT, Self Testing, etc.).
• Active use of IEC to increase demand for HIV
testing

10. Treat
• Accelerate uptake of ART
• Improve ART retention by engaging
community/NGOs/ private sector.
• Ensure supportive environment for achieving
universal access to ART
• Address co-morbidities of HIV infection to lower
mortality and morbidity.

11. Objective
• Reduce new infection of HIV by 80% by 2024.
• Link 95% of PLHIV with services by 2024.
• Ensure ART initiation and retention of 95% of
PLHIV for sustained viral load suppression by
2024.
• Eliminate mother to child transmission of HIV
and Syphilis by 2024.

12. • Eliminate HIV related stigma and
discrimination by 2020.
• Facilitate sustainable NACP service delivery
by 2024.

14. By 2024
• Estimated new infections will reduce from
102,226 (2010) to < 21,000 per year.
• 2.14 million PLHIV of the total estimated PLHIV
(2.25 million) would know their status.
• 2.03 million PLHIV would be put on ART.
• 1.93 million PLHIV would be retained on
treatment and have HIV VL <1000 copies/Ml.

15. • Fulfilment of<50 cases of new paediatric HIV
infections per 100,000 live births with a
mother-to-child transmission rate of <5% by
2020 and maintenance of same thereof.
• Attainment of <50 cases of congenital syphilis
per 100,000 live births and maintenance of
same thereof.
• HIV/AIDS will be perceived as chronic
manageable disease with no stigma and
discrimination attached to it.

16. • Key components of the NACP such as
prevention outreach, testing, treatment,
prevention of mother-to-child transmission,
viral load suppression, care and support, as
well as social protection schemes will continue
through 100% domestic funding.

17. Major strategies
• Fast-Tracked Flexible Approach to HIV
Programming
• The HIV epidemic is not uniform in all States/
UTs of India, and even within the State/UTs,
there are vast differences in both situational
and epidemic trends.

18. • Leveraging integration of the AIDS
Programme with the National Health Mission
• Many components of the NACP require
support from general health systems and other
programmes.
• For example, PPTCT is heavily dependent on
the RMNCH+A programme to get pregnant
mother
under ANC care and hence tested for HIV.

19. • Active collaboration with private sector
• Engaging public and private sector companies
through their corporate social responsibility
(CSR)functions and funds.
• Developing an Advocacy, Communication and
Social Mobilisation (ACSM) approach.

20. Indicators for monitoring NSP
progress 2017-24
• Number of people living with HIV/ AIDS (in
million) 2.25
• Percentage of HIV response financed through
domestic budget - 100%
• Percentage of condom use among key
populations and sterile needles/ syringes
among PWID-90%

21. • Number and percentage of PLHIVs who have
been diagnosed with HIV (in million) 2.14
(95%).
• Number and percentage of diagnosed PLHIVs
currently on ART (in million) 2.03 (95%).
• Percentage of PLHIVs retained and surviving
on ART -95% - 12 months.
• Percentage of PLHIV undergone VL test (in
million) 1.6.

22. • Number and percentage of PLHIV and on ART
who are virologically suppressed 1.52 (95%).
• Number and percentage of pregnant women
tested for HIV-25.69 (95%).
• Number and percentage of HIV related deaths.
• Number and percentage of new HIV infections
(Incidence)-(80%).

23. Priority areas
• Accelerating HIV Prevention in ‘at risk’
population including ‘key population.
• Expanding quality assured HIV testing with
universal access to comprehensive HIV care.
• Elimination of mother to child transmission of
HIV and syphilis.

24. • Addressing the critical enablers in HIV
programming.
• Restructuring the strategic information system
to be efficient and patient-centric.

25. Thanks